ANDA 75108, held by Pharmobedient. Nifedipine.
As of Nov 16, 2026, ANDA 75108 (Nifedipine), held by Pharmobedient, was first approved by FDA on Dec 17, 1999, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 17, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Nifedipine30MG ยท tablet, extended release;oral | Nifedipine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters